T
Tanya O. Robinson
Researcher at University of Mississippi Medical Center
Publications - 7
Citations - 300
Tanya O. Robinson is an academic researcher from University of Mississippi Medical Center. The author has contributed to research in topics: Intrinsic immunity & Viral load. The author has an hindex of 3, co-authored 7 publications receiving 52 citations.
Papers
More filters
Journal ArticleDOI
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
Carly G. K. Ziegler,Vincent N. Miao,Anna H. Owings,Andrew W. Navia,Ying Tang,Joshua D. Bromley,Peter Lotfy,Peter Lotfy,Meredith Sloan,Hannah Laird,Haley B. Williams,Micayla George,Micayla George,Micayla George,Riley S. Drake,Riley S. Drake,Riley S. Drake,Taylor Christian,Adam M. Parker,Campbell B Sindel,Molly W. Burger,Yilianys Pride,Mohammad H. Hasan,George E. Abraham,Michal Senitko,Tanya O. Robinson,Alex K. Shalek,Sarah C. Glover,Bruce H. Horwitz,Bruce H. Horwitz,Jose Ordovas-Montanes +30 more
TL;DR: In this article, the authors performed scRNA-seq on nasopharyngeal swabs from 58 healthy and COVID-19 participants, and identified genes associated with susceptibility, resistance, or infection response.
Posted ContentDOI
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Carly G. K. Ziegler,Vincent N. Miao,Anna H. Owings,Andrew W. Navia,Ying Tang,Joshua D. Bromley,Peter Lotfy,Peter Lotfy,Meredith Sloan,Hannah Laird,Haley B. Williams,Micayla George,Micayla George,Micayla George,Riley S. Drake,Riley S. Drake,Riley S. Drake,Taylor Christian,Adam M. Parker,Campbell B Sindel,Molly W. Burger,Yilianys Pride,Mohammad H. Hasan,George E. Abraham,Michal Senitko,Tanya O. Robinson,Alex K. Shalek,Sarah C. Glover,Bruce H. Horwitz,Bruce H. Horwitz,Jose Ordovas-Montanes +30 more
TL;DR: This work defines both protective and detrimental host responses to SARS-CoV-2, determines the direct viral targets of infection, and suggests that failed anti-viral epithelial immunity in the nasal mucosa may underlie the progression to severe COVID-19.
Journal ArticleDOI
The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Rachel C. Newsome,Josee Gauthier,Maria C. Hernandez,George E. Abraham,Tanya O. Robinson,Haley B. Williams,Meredith Sloan,Anna H. Owings,Hannah Laird,Taylor Christian,Yilianys Pride,Kenneth J. Wilson,Mohammad H. Hasan,Adam M. Parker,Michal Senitko,Sarah C. Glover,Sarah C. Glover,Raad Z. Gharaibeh,Christian Jobin +18 more
TL;DR: In this paper, the relationship between intestinal microbiota and SARS-CoV-2-mediated pathogenicity in a United States, majority African American cohort was investigated, where 16S rRNA sequencing and qPCR analysis was performed on fecal DNA/RNA.
Journal ArticleDOI
Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy
Julia J. Liu,Meredith Sloan,Anna H. Owings,Erika L. Figgins,Josee Gauthier,Raad Z. Gharaibeh,Tanya O. Robinson,Haley B. Williams,Campbell B Sindel,Fremel J. Backus,Krishna K. Ayyalasomayajula,Adam M. Parker,Michal Senitko,George E Abraham,Brian Claggett,Bruce H. Horwitz,Christian Jobin,Robert M. Adelman,Gill Diamond,Sarah C. Glover +19 more
TL;DR: In this paper, the authors performed a prospective study of hospitalized coronavirus disease 2019 (COVID-19) patients and COVID-negative controls to understand how Proton pump inhibitor (PPI) use may affect angiotensin-converting enzyme 2 (ACE2) expression and stool SARS-CoV-2 RNA analysis.
Journal ArticleDOI
Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia.
Liza Konnikova,Liza Konnikova,Tanya O. Robinson,Anna H. Owings,James F. Shirley,Elisabeth M. Davis,Ying Tang,Ying Tang,Sarah Wall,Jian Li,Mohammad H. Hasan,Raad Z. Gharaibeh,Lybil B. Mendoza Alvarez,Lisa K. Ryan,Andria L. Doty,Jack Chovanec,Michael P. O'Connell,Dianne Grunes,William Daley,Emeran A. Mayer,Lin Chang,Julia Liu,Scott B. Snapper,Joshua D. Milner,Sarah C. Glover,Sarah C. Glover,Jonathan J. Lyons +26 more
TL;DR: In this article, the prevalence of HαT in an irritable bowel syndrome cohort and associated immunologic characteristics that may distinguish patients with HαTs from patients without HTs were determined.